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How to measure comorbidity: a critical review of available methods
We would like to thank Rozzini et al. for their letter
regarding the Geriatric Index of Comorbidity (GIC). The
GIC was not included in our review [1] because it was only
recently published [2]. On the basis of their publication and
Letter to the Editor, we will briefly review the GIC according
to the criteria applied in our review of comorbidity mea-
sures [1].
The selection of the 15 diseases is based on the prevalence
of these conditions in an elderly population [2]. This selec-
tion and the severity rating of the condition are based on the
Index of Coexistent Disease—Disease Severity (ICED-DS)
[1,3]. Subsequently, the GIC class (I—IV) is determined.
Although the authors give a clear description of this classifi-
cation, they do not describe the rationale for it. Medical charts
are used to collect the information. Their study population
consisted of 493 elderly patients admitted to the Geriatric
Evaluation and Rehabilitation Unit [2] and 1402 hospitalized
elderly patients (letter). Concurrent validity was studied by
correlating the GIC with the number of comorbid diseases
(selected from the 15 diseases and stratified into four levels)
and the sum of severities of the 15 conditions (stratified into
four levels). The correlation coefficients were 0.14 and 0.53,
respectively [2]. Unfortunately, the authors do not explain
why they decided to use stratification. Predictive validity was
assessed by using the G1C in multivariate models predicting
basic activities of daily living (BADL) (r2 = 0.32) and Physi-
cal Performance Test (PPT) (r 2 = 0.39). A relative risk (RR)
of 2.3 (95% confidence interval [CI] 1.7-3.1) was found
for the GIC in a multivariate model predicting 12-month
mortality [2]. An RR of 1.1 (95% CI 1.0-2.1) was found
for Class III, and an RR of 3.0 (95% CI 1.7-5.3) was
found for Class IV in a multivariate Cox regression model
predicting 6-month mortality (letter). The relationships be-
tween the scores for the GIC and BADL, PPT, Minimal
Mental State Examination, Acute Physiological and Chronic
Health Evaluation II (APACHE II), and length of stay sup-
port the construct validity. Inter-rater agreement is 89%, and
intra-rater agreement is 97%.
The authors showed that the GIC was independently asso-
ciated with BADL and PPT after adjustment for the severity
of individual diseases. Thus, the GIC seems to contain some
information that is not obtained by using the number of
diseases and their severity ratings only. In our review, we
discussed the possibility that certain disease combinations
may have synergistic effects, leading to more disability than
would be expected on the basis of addition alone. Knowing
these combinations would provide extra information, so it
would be very interesting to study these phenomena in depth.
Although the GIC certainly seems promising, further vali-
dation studies are needed. We would be very interested in
studies comparing the GIC with other comorbidity indices
mentioned in our review and in more extensive reliability
studies. However, on the basis of the information that is
currently available, we would not be able to add the GIC
to the list of recommended measures of comorbidity.
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